{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-26-000005","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.725210+00:00","generated_at":"2026-05-15T23:38:53.233147+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"vTv Therapeutics posts updated investor slide presentation on February 26, 2026","bullets":["Company posted updated investor presentation dated February 2026 on its website.","Presentation will be used in meetings with investors, analysts, and other parties.","Presentation attached as Exhibit 99.1 to Current Report on Form 8-K filed February 26, 2026.","CEO Paul J. Sekhri signed the 8-K filing for vTv Therapeutics Inc. (Nasdaq: VTVT)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-26-000005","json":"https://secwatch.observer/filing/0001641489-26-000005.json","markdown":"https://secwatch.observer/filing/0001641489-26-000005.md","text":"https://secwatch.observer/filing/0001641489-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/0001641489-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000005/vtvt-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T23:38:53.233147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}